| Literature DB >> 27707835 |
Yuan He1, Fan Yang2, Dongqin Mu3, Yuan Xing4, Xin Li5.
Abstract
OBJECTIVES: Main study aim was as follows: (1) to explore the usefulness of the theory of planned behaviour (TPB) model in predicting Chinese hospital pharmacists' intention to provide clinical pharmacy services (CPSs), including auxiliary CPSs and core CPSs; (2) to identify the main factors affecting the Chinese hospital pharmacists' intention to provide core CPSs based on TPB quantitatively.Entities:
Keywords: Attitude; Clinical Pharmacy Services; Intention; Pharmacist; Structural equation model; Theory of planned behavior
Mesh:
Year: 2016 PMID: 27707835 PMCID: PMC5073478 DOI: 10.1136/bmjopen-2016-012775
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1A framework of the theory of planned behaviour.
Figure 2Research model of pharmacists’ intention to provide clinical pharmacy services based on TPB. INTA, intention to provide auxiliary clinical pharmacy services; INTC, intention to provide core clinical pharmacy services; PB, past behaviours related clinical pharmacy services; PBC, perceived behavioural control; SN, subjective norm; TPB, theory of planned behaviour.
Demographics and relevant characteristics of participants (n=416)
| The variables | Values | n (%) |
|---|---|---|
| Gender | Male | 124 (29.8) |
| Female | 292 (70.2) | |
| Years of practice | 3 or less | 104 (25.0) |
| 4–10 | 145 (34.9) | |
| 11–20 | 97 (23.3) | |
| >20 | 70 (16.8) | |
| Education level | Bachelor's degree and below | 263 (63.2) |
| Master's degree | 134 (32.2) | |
| Doctoral degree | 19 (4.6) | |
| Current position | Junior pharmacist | 168 (40.3) |
| Pharmacist-in-charge | 167 (40.1) | |
| Deputy chief pharmacist | 65 (15.6) | |
| Chief pharmacist | 16 (3.8) | |
| Types of hospital | Tertiary hospital class A | 377 (90.6) |
| Tertiary hospital class B | 20 (4.8) | |
| Secondary hospital | 19 (4.6) | |
| Work role | Clinical Pharmacist | 222 (53.4) |
| Dispensing pharmacist | 160 (38.5) | |
| Other | 34 (8.1) |
Survey statements and descriptive statistics by conduct (n=416)
| Construct | Survey statement | Mean±SD | Positive/high frequent (n, %) | Negative/low frequent (n, %) |
|---|---|---|---|---|
| Attitude | CPSs provided by hospital pharmacists can help physicians to avoid medication errors and enhance the safety of drug use effectively | 4.42±0.65 | 382 (91.8) | 1 (0.2) |
| CPSs provided by hospital pharmacists can promote the level of rational uses of drugs and optimise the efficacy of medication | 4.35±0.67 | 377 (90.7) | 3 (0.7) | |
| CPSs provided by hospital pharmacists can reduce the drug costs and enhance the economics of medication effectively | 3.87±0.90 | 233 (56.1) | 25 (6.0) | |
| CPSs provided by hospital pharmacists can promote the quality of medical services effectively | 4.22±0.73 | 320 (77.0) | 9 (2.2) | |
| Participation in CPSs will improve my achievability of work | 4.10±0.85 | 332 (79.8) | 15 (3.6) | |
| Participation in CPSs will improve my job satisfaction | 3.97±0.80 | 317 (76.2) | 13 (3.1) | |
| SN | Most people who are important to me approve of me providing CPSs | 3.75±1.05 | 285 (68.5) | 37 (8.9) |
| Physicians in our hospital would approve of me providing CPSs | 3.27±0.97 | 180 (43.3) | 69 (16.6) | |
| Patients in our hospital would like to see me provide CPSs | 3.27±0.98 | 188 (45.2) | 69 (16.6) | |
| Pharmacists whose opinions I value in our hospital would like to approve of me providing CPSs | 3.25±1.05 | 189 (45.4) | 64 (15.4) | |
| PBC | I think I have necessary knowledge and skills to provide CPSs | 3.46±0.92 | 214 (51.5) | 56 (13.5) |
| Pharmacists in our hospital have necessary hardware and software support to provide CPSs | 3.33±1.10 | 206 (49.6) | 88 (21.2) | |
| Regulations and management model of our hospital are enough to support me participating in CPSs | 3.49±0.99 | 230 (55.3) | 50 (12.0) | |
| PB | Involving in physicians’ ward rounds to make suggestions for drug-therapy plans for patients | 2.55±1.55 | 145 (34.9) | 214 (51.4) |
| Implementing pharmaceutical care for hospitalized patients | 2.50±1.57 | 139 (33.4) | 234 (56.3) | |
| Reviewing the prescription to detect and prevent prescription errors | 2.98±1.60 | 199 (47.8) | 173 (41.6) | |
| Writing medication records for hospitalized patients | 2.57±1.57 | 155 (37.2) | 222 (53.4) | |
| Assisting physicians in monitoring the hospitalized patients’ ADRs | 2.98±1.52 | 182 (43.8) | 165 (39.7) | |
| INTA | I intend to review prescription or medical order record to detect and prevent prescription errors | 4.16±0.69 | 359 (86.3) | 5 (1.2) |
| If necessary, I intent to involve in implementing therapeutic drug monitoring | 4.15±0.70 | 367 (88.3) | 7 (1.7) | |
| I will explain the results of therapeutic drug monitoring to the patients | 4.14±0.73 | 363 (87.2) | 9 (2.2) | |
| I intent to write medication records for hospitalized patients | 3.85±0.88 | 304 (73.1) | 31 (7.5) | |
| I intent to counsel patients regarding the safe and appropriate use of their medications and provide patient education | 4.29±0.60 | 389 (93.5) | 2 (0.5) | |
| I intent to implement pharmaceutical care for hospitalized patients | 4.12±0.77 | 358 (86.1) | 14 (3.4) | |
| INTC | I intent to involve in physicians’ ward rounds to make suggestions for drug-therapy plans for patients and share the responsibilities for medication with physicians | 3.94±0.92 | 325 (78.1) | 33 (7.9) |
| I intent to involve in physicians’ case discussions to make suggestions for drug-therapy plans for patients and share the responsibilities for medication with physicians | 3.87±0.94 | 31 (75.3) | 37 (8.9) | |
| I intent to involve in physicians’ consultation to make suggestions for drug-therapy plans for patients and share the responsibilities for medication with physicians | 3.86±0.94 | 314 (75.5) | 38 (9.1) |
ADR, adverse drug reaction; CPS, clinical pharmacy service; INTA, intention to provide auxiliary clinical pharmacy services; INTC, intention to provide core clinical pharmacy services; PB, past behaviours related clinical pharmacy services; PBC, perceived behavioural control; SN, subjective norm.
Correlations among variables
| R | AVE | CR | PB | A | INTA | INTC | PBC | SN | |
|---|---|---|---|---|---|---|---|---|---|
| PB | 0.91 | 0.74 | 0.93 | ||||||
| A | 0.88 | 0.63 | 0.91 | 0.12 | |||||
| INTA | 0.89 | 0.64 | 0.92 | 0.22 | 0.40 | ||||
| INTC | 0.93 | 0.88 | 0.96 | 0.23 | 0.42 | 0.71 | |||
| PBC | 0.73 | 0.65 | 0.85 | 0.23 | 0.22 | 0.25 | 0.24 | ||
| SN | 0.73 | 0.56 | 0.83 | 0.19 | 0.37 | 0.25 | 0.31 | 0.55 |
Square roots of AVE are bolded, shown on diagonal.
A, attitudes; AVE, average variance extracted; CR, composite reliability; INTA, intention to provide auxiliary clinical pharmacy services; INTC, intention to provide core clinical pharmacy services; PB, past behaviours regarding clinical pharmacy services; PBC, perceived behavioural control; R, Cronbach's α; SN, subjective norm.
Factor loadings
| PB | A | INTA | INTC | PBC | SN | |
|---|---|---|---|---|---|---|
| PB1 | 0.81 | |||||
| PB2 | 0.90 | |||||
| PB3 | 0.91 | |||||
| PB4 | 0.77 | |||||
| PB5 | 0.90 | |||||
| A1 | 0.85 | |||||
| A2 | 0.85 | |||||
| A3 | 0.76 | |||||
| A4 | 0.84 | |||||
| A5 | 0.74 | |||||
| A6 | 0.73 | |||||
| INTA1 | 0.84 | |||||
| INTA2 | 0.76 | |||||
| INTA3 | 0.80 | |||||
| INTA4 | 0.85 | |||||
| INTA5 | 0.75 | |||||
| INTA6 | 0.82 | |||||
| INTC1 | 0.93 | |||||
| INTC2 | 0.95 | |||||
| INTC3 | 0.94 | |||||
| PBC1 | 0.89 | |||||
| PBC2 | 0.80 | |||||
| PBC3 | 0.72 | |||||
| SN1 | 0.78 | |||||
| SN2 | 0.71 | |||||
| SN3 | 0.76 | |||||
| SN4 | 0.72 |
PBC1–PBC3, the three items measuring respondents’ perceived behavioural control; SN1–SN4: the four items measuring respondents’ subjective norm.
A1–A6, the six items measuring respondents’ attitudes; PB1-PB4, the four items measuring respondents’ frequency of past behaviours related clinical pharmacy services; INTA1–INTA6, the six items measuring respondents’ intention to provide auxiliary clinical pharmacy services; INTC1–INTC3, the three items measuring respondents’ intention to provide core clinical pharmacy services.
A, attitudes; INTA, intention to provide auxiliary clinical pharmacy services; INTC, intention to provide core clinical pharmacy services; PB, past behaviours related clinical pharmacy services; PBC, perceived behavioural control; SN, subjective norm.
Hypothesis testing results
| Hypothesis | Path | Path coefficient (ß) | t value | Result |
|---|---|---|---|---|
| H1a | Attitude → intention to provide auxiliary CPSs | 0.35 | 6.63 | Supported |
| H1b | Attitude → intention to provide core CPSs | 0.12 | 2.67 | Supported |
| H2a | Perceived behaviour control → intention to provide auxiliary CPSs | 0.12 | 2.37 | Supported |
| H2b | Perceived behaviour control → intention to provide core CPSs | −0.01 | 0.24 | Not supported |
| H3a | Subjective norms → intention to provide auxiliary CPSs | 0.03 | 0.42 | Not supported |
| H3b | Subjective norms → intention to provide core CPSs | 0.10 | 2.08 | Supported |
| H4a | Past behaviour → intention to provide auxiliary CPSs | 0.15 | 3.34 | Supported |
| H4b | Past behaviour → intention to provide core CPSs | 0.06 | 1.75 | Not supported |
| H5 | Intention to provide auxiliary CPSs → intention to provide core CPSs | 0.63 | 15.61 | Supported |
CPS, clinical pharmacy service.
Figure 3Path diagram for research model. INTA, intention to provide auxiliary clinical pharmacy services; INTC, intention to provide core clinical pharmacy services; PB, past behaviours related clinical pharmacy services; PBC, perceived behavioural control; SN, subjective norm.